×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NVRO – nevro corp. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NVRO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/30
02:02 am
nvro
Nevro Corp. (NYSE: NVRO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Neutral
Report
Nevro Corp. (NYSE: NVRO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/23
05:50 pm
nvro
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMPS, NVRO, PLYA on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMPS, NVRO, PLYA on Behalf of Shareholders
3/22
02:04 am
nvro
Nevro Corp. (NYSE: NVRO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Nevro Corp. (NYSE: NVRO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/21
11:30 am
nvro
NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp. - NVRO
Low
Report
NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp. - NVRO
3/19
08:07 pm
nvro
Here's Why you Should Retain Nevro Stock in Your Portfolio Now [Yahoo! Finance]
Low
Report
Here's Why you Should Retain Nevro Stock in Your Portfolio Now [Yahoo! Finance]
3/14
02:00 am
nvro
Nevro Corp. (NYSE: NVRO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Nevro Corp. (NYSE: NVRO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/6
02:09 am
nvro
Nevro Corp. (NYSE: NVRO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Nevro Corp. (NYSE: NVRO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/4
04:45 pm
nvro
Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results [Yahoo! Finance]
Low
Report
Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
4/3
04:31 pm
nvro
Form 4 NEVRO CORP For: Apr 03 Filed by: Kosaraju Sridhar
Neutral
Report
Form 4 NEVRO CORP For: Apr 03 Filed by: Kosaraju Sridhar
4/3
04:31 pm
nvro
Form 4 NEVRO CORP For: Apr 03 Filed by: mcCormick Shawn
Neutral
Report
Form 4 NEVRO CORP For: Apr 03 Filed by: mcCormick Shawn
4/3
04:31 pm
nvro
Form 4 NEVRO CORP For: Apr 03 Filed by: MacLeod Roderick H.
Neutral
Report
Form 4 NEVRO CORP For: Apr 03 Filed by: MacLeod Roderick H.
4/3
04:31 pm
nvro
Form 4 NEVRO CORP For: Apr 03 Filed by: GROSSMAN D KEITH
Neutral
Report
Form 4 NEVRO CORP For: Apr 03 Filed by: GROSSMAN D KEITH
4/3
04:30 pm
nvro
Form 4 NEVRO CORP For: Apr 03 Filed by: Prange Karen
Neutral
Report
Form 4 NEVRO CORP For: Apr 03 Filed by: Prange Karen
4/3
04:30 pm
nvro
Form 4 NEVRO CORP For: Apr 03 Filed by: Karros Kirt P
Neutral
Report
Form 4 NEVRO CORP For: Apr 03 Filed by: Karros Kirt P
4/3
04:30 pm
nvro
Form 4 NEVRO CORP For: Apr 03 Filed by: Rashid Kashif
Neutral
Report
Form 4 NEVRO CORP For: Apr 03 Filed by: Rashid Kashif
4/3
04:30 pm
nvro
Form 4 NEVRO CORP For: Apr 03 Filed by: Christoforou Christofer
Neutral
Report
Form 4 NEVRO CORP For: Apr 03 Filed by: Christoforou Christofer
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/6
Q3/2019 9/30/2019 EPS -0.580 ZacksConsensus -0.810 ActVsEst 0.230 - Beat
21.3%
8/9 Nevro Corp (NYSE: NVRO) had its price target raised by analysts at Canaccord Genuity from $50.00 to $59.00. They now have a "hold" rating on the stock. 17.8%
5/10 Nevro Corp (NYSE: NVRO) had its price target lowered by analysts at JMP Securities from $80.00 to $70.00. They now have a "market outperform" rating on the stock. 15.8%
4/1 Nevro sees Q1 revenue of almost $87M; shares up 2% after hours [Seeking Alpha] 11.3%
4/3 Nevro Announces the Full Exercise of the Underwriter's Option to Purchase Additional Common Stock and the Underwriter's Over-allotment Option to Purchase Additional Convertible Senior Notes 10.2%
1/27 Nevro Corp (NYSE: NVRO) had its price target raised by analysts at JMP Securities to $150.00. They now have an "outperform" rating on the stock. 7.1%
8/10 Nevro Corp (NVRO) Q2 2019 Earnings Call Transcript [The Motley Fool] 6.7%
2/25 Form 8-K NEVRO CORP For: Feb 25 5.6%
1/15 Nevro Corp (NYSE: NVRO) had its price target raised by analysts at UBS Group AG from $77.00 to $84.00. They now have a "sell" rating on the stock. 3.5%
10/2 Form 4 NEVRO CORP For: Sep 30 Filed by: Vale Brad 3.2%
8/9 Nevro Corp (NYSE: NVRO) had its price target raised by analysts at Canaccord Genuity from $50.00 to $59.00. They now have a "hold" rating on the stock. 17.8%
5/10 Nevro Corp (NYSE: NVRO) had its price target lowered by analysts at JMP Securities from $80.00 to $70.00. They now have a "market outperform" rating on the stock. 15.8%
4/1 Nevro sees Q1 revenue of almost $87M; shares up 2% after hours [Seeking Alpha] 11.3%
4/3 Nevro Announces the Full Exercise of the Underwriter's Option to Purchase Additional Common Stock and the Underwriter's Over-allotment Option to Purchase Additional Convertible Senior Notes 10.2%
1/27 Nevro Corp (NYSE: NVRO) had its price target raised by analysts at JMP Securities to $150.00. They now have an "outperform" rating on the stock. 7.1%
8/10 Nevro Corp (NVRO) Q2 2019 Earnings Call Transcript [The Motley Fool] 6.7%
2/25 Form 8-K NEVRO CORP For: Feb 25 5.6%
1/15 Nevro Corp (NYSE: NVRO) had its price target raised by analysts at UBS Group AG from $77.00 to $84.00. They now have a "sell" rating on the stock. 3.5%
10/2 Form 4 NEVRO CORP For: Sep 30 Filed by: Vale Brad 3.2%
TOP News Decliners
4/13
Sangamo And Biogen Tie Up, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha]
-6.9%
3/27 Form SC 13G NEVRO CORP Filed by: HealthCor Management, L.P. -6.3%
10/22 Nevro Corp (NYSE: NVRO) is now covered by analysts at Oppenheimer Holdings Inc.. They set a "market perform" rating on the stock. -4.2%
5/9 Q1/2019 3/31/2019 EPS -1.450 ZacksConsensus -0.660 ActVsEst (0.790) - Miss -4.1%
11/7 Edited Transcript of NVRO earnings conference call or presentation 6-Nov-19 9:30pm GMT [Yahoo! Finance News] -4.1%
2/28 Form 8-K NEVRO CORP For: Feb 27 -4.0%
2/26 Nevro Corp (NYSE: NVRO) had its price target raised by analysts at Leerink Swann from $146.00 to $158.00. They now have a "positive" rating on the stock. -3.5%
8/23 Nevro to Present at Morgan Stanley 17th Annual Healthcare Conference -3.2%
4/21 Nevro to Report First Quarter 2020 Financial Results -2.7%
4/14 Form 4 NEVRO CORP For: Apr 12 Filed by: GROSSMAN D KEITH -2.7%
3/27 Form SC 13G NEVRO CORP Filed by: HealthCor Management, L.P. -6.3%
10/22 Nevro Corp (NYSE: NVRO) is now covered by analysts at Oppenheimer Holdings Inc.. They set a "market perform" rating on the stock. -4.2%
5/9 Q1/2019 3/31/2019 EPS -1.450 ZacksConsensus -0.660 ActVsEst (0.790) - Miss -4.1%
11/7 Edited Transcript of NVRO earnings conference call or presentation 6-Nov-19 9:30pm GMT [Yahoo! Finance News] -4.1%
2/28 Form 8-K NEVRO CORP For: Feb 27 -4.0%
2/26 Nevro Corp (NYSE: NVRO) had its price target raised by analysts at Leerink Swann from $146.00 to $158.00. They now have a "positive" rating on the stock. -3.5%
8/23 Nevro to Present at Morgan Stanley 17th Annual Healthcare Conference -3.2%
4/21 Nevro to Report First Quarter 2020 Financial Results -2.7%
4/14 Form 4 NEVRO CORP For: Apr 12 Filed by: GROSSMAN D KEITH -2.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: